Elos Medtech Past Earnings Performance

Past criteria checks 2/6

Elos Medtech has been growing earnings at an average annual rate of 23.4%, while the Medical Equipment industry saw earnings declining at 9.5% annually. Revenues have been growing at an average rate of 9.3% per year. Elos Medtech's return on equity is 7%, and it has net margins of 5.4%.

Key information

23.4%

Earnings growth rate

22.9%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate9.3%
Return on equity7.0%
Net Margin5.4%
Next Earnings Update29 Feb 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Elos Medtech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0IZX Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 231,0185518321
30 Jun 239985518423
31 Mar 239617617124
31 Dec 228897516624
30 Sep 228439415824
30 Jun 227999015622
31 Mar 227477914819
31 Dec 217247613918
30 Sep 216946712614
30 Jun 216556211314
31 Mar 215925110615
31 Dec 205803610916
30 Sep 205843311818
30 Jun 205932912217
31 Mar 206582913117
31 Dec 196893913317
30 Sep 197003513121
30 Jun 196973212922
31 Mar 196792912621
31 Dec 186452112119
30 Sep 186252411814
30 Jun 186032111313
31 Mar 185932310914
31 Dec 175782310614
30 Sep 175621810815
30 Jun 175562310716
31 Mar 175522910415
31 Dec 165522610115
30 Sep 16555279615
30 Jun 16551209515
31 Mar 16539159415
31 Dec 15504169314
30 Sep 15474178713
30 Jun 15436238011
31 Mar 15398267210
31 Dec 14381236310
30 Sep 14371256210
30 Jun 14369186010
31 Mar 1436617599
31 Dec 1336817599
30 Sep 13396206610
30 Jun 13413187211
31 Mar 13424128012
31 Dec 1243488814

Quality Earnings: 0IZX has high quality earnings.

Growing Profit Margin: 0IZX's current net profit margins (5.4%) are lower than last year (11.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0IZX's earnings have grown significantly by 23.4% per year over the past 5 years.

Accelerating Growth: 0IZX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 0IZX had negative earnings growth (-41.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (-12.2%).


Return on Equity

High ROE: 0IZX's Return on Equity (7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/21 16:16
End of Day Share Price 2023/12/18 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elos Medtech AB (publ) is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oskar VikströmABG Sundal Collier Sponsored
Andreas KvistRedeye